| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | K01OH012961 | Dynamics of Emotion Regulation, Trauma, and Grief Among Those Impacted by the World Trade Center Attacks | 01 | 1 | CDC | 11/17/2025 | $0 |
| | 2026 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01OH012485 | Grief and health-related quality of life in WTCHR Survivors: Associations with bereavement, trauma exposures, and mental and physical health conditions | 02 | 3 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01GM117155 | Regulation of microtubule organizing centers during mammalian gametogenesis | 000 | 10 | NIH | 11/13/2025 | $0 |
| | 2026 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01OH012485 | Grief and health-related quality of life in WTCHR Survivors: Associations with bereavement, trauma exposures, and mental and physical health conditions | 02 | 3 | CDC | 11/13/2025 | $0 |
| | 2026 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21MH134244 | Determining the interplay of MAIT cells and the translocated microbiome in HIV-induced neuroinflammation | 000 | 1 | NIH | 11/26/2025 | $0 |
| | 2026 | 2022 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01OH012485 | Grief and health-related quality of life in WTCHR Survivors: Associations with bereavement, trauma exposures, and mental and physical health conditions | 02 | 3 | CDC | 11/13/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $20,921,529 ) (Continued on the next page) |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01AI170033 | Mitigation of Radiation Induced Immune Dysfunction by PrC-210 Treatment | 000 | 4 | NIH | 6/18/2025 | $423,626 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01NS119594 | Calcium Dysregulation and Cell Function in Spinal Muscular Atrophy | 001 | 5 | NIH | 8/5/2025 | $38,123 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01NS119594 | Calcium Dysregulation and Cell Function in Spinal Muscular Atrophy | 000 | 5 | NIH | 2/17/2025 | $343,117 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21NS136126 | Inflammation and white matter microstructural alterations after OP exposure | 000 | 2 | NIH | 8/1/2025 | $224,146 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01AI187053 | Development of angiogenin as a novel radiation medical countermeasure for acute radiation syndrome | 000 | 1 | NIH | 9/4/2025 | $554,698 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U19AI189178 | Center for Immunological Interventions against Gonorrhea (CIIG) | 000 | 1 | NIH | 8/12/2025 | $4,362,124 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI194027 | Evaluation of PEG-BPEI as a potential mitigator against gastrointestinal acute radiation syndrome | 000 | 1 | NIH | 7/29/2025 | $149,008 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI176379 | Structure-based identification of pan-arenavirus sites of vulnerability | 000 | 1 | NIH | 7/23/2025 | $536,871 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01LM014784 | Retrospective Magnetic Resonance Image Harmonization for Robust Federated Learning | 000 | 1 | NIH | 7/23/2025 | $320,622 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01CA252468 | ATR Dependency as a Novel Therapeutic Target in Lethal RB Deficient ProstateCancer | 004 | 7 | NIH | 7/16/2025 | $193,926 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01NS145076 | Astrocyte Calcium Signaling in Chronic Pain. | 000 | 1 | NIH | 7/17/2025 | $372,880 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI190739 | Delineating the kinetics of spinal pathology in the EV-D68 infected ferret model | 000 | 1 | NIH | 2/1/2025 | $217,976 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21OD034471 | Identifying the radioprotective potential of radiation-resistant fungi using Drosophila | 000 | 2 | NIH | 8/7/2025 | $199,469 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21DC021516 | Improving Interpretation of Hearing- Related Patient Reported Outcomes for Bilingual Adults | 000 | 2 | NIH | 7/29/2025 | $150,617 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI174937 | QALYs, Comorbidities, and Cost-effectiveness of HIV Care in the Department of Defense vs the Veterans Health Administration | 000 | 2 | NIH | 6/11/2025 | $204,932 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | United States Military HIV Research Program (MHRP) Clinical Trials Unit | 003 | 12 | NIH | 4/29/2025 | $154,656 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | United States Military HIV Research Program (MHRP) Clinical Trials Unit | 002 | 12 | NIH | 1/10/2025 | $692,302 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01CA255232 | Isoform-specific signaling as a determinant of RAS-driven oncogenesis | 000 | 4 | NIH | 3/6/2025 | $313,951 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01CA255232 | Isoform-specific signaling as a determinant of RAS-driven oncogenesis | 001 | 4 | NIH | 5/22/2025 | $34,883 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01NS123252 | Antiglutamatergic Therapy to Protect the Brain Against Nerve Agents | 000 | 4 | NIH | 8/4/2025 | $721,888 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | United States Military HIV Research Program (MHRP) Clinical Trials Unit | 003 | 12 | NIH | 4/29/2025 | $692,302 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | United States Military HIV Research Program (MHRP) Clinical Trials Unit | 002 | 12 | NIH | 1/10/2025 | $154,654 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI168295 | Mechanistic elucidation of pathogenic CBM complex mutations associated with atopic disease | 000 | 3 | NIH | 7/2/2025 | $677,257 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01HD114180 | Pluripotent stem cell-derived organoid model of human gonad development, functions, and disorders | 000 | 3 | NIH | 7/14/2025 | $584,060 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI177698 | Maturation of human humoral immunity through repeat malaria challenges | 000 | 3 | NIH | 4/10/2025 | $778,280 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R35GM139619 | Temporal and Metabolic Regulation of Restimulation-Induced Cell Death (RICD) in Human T Cells | 002 | 5 | NIH | 8/6/2025 | $38,123 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R35GM139619 | Temporal and Metabolic Regulation of Restimulation-Induced Cell Death (RICD) in Human T Cells | 001 | 5 | NIH | 12/9/2024 | $343,117 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21ES035984 | Mechanisms of Radiation-induced Hemolysis | 000 | 1 | NIH | 9/18/2025 | $340,383 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | F31NS143385 | Determine the Role of Microglia in Adult Circuit Remodeling in a Mouse Model of Whisker Denervation | 000 | 1 | NIH | 9/23/2025 | $33,538 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI174908 | A new strategy to eliminate HIV-1-infected cells by unlocking the Env trimer | 000 | 3 | NIH | 8/12/2025 | $690,610 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI176520 | Designing HIV-1 envelope immunogens to maximize neutralization breadth through use of multiple founder envelope antigens | 001 | 3 | NIH | 9/5/2025 | $1,759,382 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01MH130197 | Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence | 000 | 4 | NIH | 6/11/2025 | $402,223 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01MH130197 | Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence | 000 | 4 | NIH | 6/11/2025 | $571,837 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R35GM140792 | Regulation of cytoplasmic dynein in vivo | 001 | 5 | NIH | 8/25/2025 | $381,240 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21OD038406 | The Mouse Model System for Targeted Trimming of Disease Susceptibility Loci | 000 | 1 | NIH | 4/24/2025 | $261,017 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | K01OH012961 | Dynamics of Emotion Regulation, Trauma, and Grief Among Those Impacted by the World Trade Center Attacks | 00 | 1 | CDC | 7/30/2025 | $137,887 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI155983 | Evaluation of Antibody Responses Elicited by Zika Vaccination in Flavivirus-naïve and -experienced Individuals | 000 | 5 | NIH | 4/22/2025 | $816,770 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R35GM157233 | Regulation of protein synthesis during cellular stress | 000 | 1 | NIH | 4/17/2025 | $372,880 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AA030041 | Leveraging genetic and electronic health record data to identify novel targets and drugs for treating alcohol use disorder | 000 | 4 | NIH | 8/28/2025 | $544,668 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01GM117155 | Regulation of microtubule organizing centers during mammalian gametogenesis | 001 | 11 | NIH | 4/16/2025 | $342,762 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01HL167048 | COVID-19 airway inflammation is due to Spike inhibition of CFTR signaling | 001 | 3 | NIH | 8/19/2025 | $63,538 |
| | 2025 | 2025 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01HL167048 | COVID-19 airway inflammation is due to Spike inhibition of CFTR signaling | 000 | 3 | NIH | 1/9/2025 | $571,842 |
|
